Cargando…
Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature
Cytokine release syndrome (CRS) is a phenomenon of immune hyperactivation described in the setting of immunotherapy. Unlike other immune-related adverse events, CRS triggered by immune checkpoint inhibitors (ICIs) is not well described. The clinical characteristics and course of 25 patients with ICI...
Autores principales: | Tay, Sen Hee, Toh, Michelle Min Xuan, Thian, Yee Liang, Vellayappan, Balamurugan A., Fairhurst, Anna-Marie, Chan, Yiong Huak, Aminkeng, Folefac, Bharwani, Lavina D., Huang, Yiqing, Mak, Anselm, Wong, Alvin Seng Cheong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831742/ https://www.ncbi.nlm.nih.gov/pubmed/35154124 http://dx.doi.org/10.3389/fimmu.2022.807050 |
Ejemplares similares
-
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
por: Huang, Yiqing, et al.
Publicado: (2023) -
Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study
por: Lee, Pei Yi, et al.
Publicado: (2021) -
Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors—Navigating the Radiologic Potpourri
por: Wong, Alvin, et al.
Publicado: (2021) -
Paraneoplastic Necrotizing Myelopathy in a Patient With Newly Diagnosed Diffuse Large B Cell Lymphoma
por: Lee, Chau Hung, et al.
Publicado: (2011) -
Are You a P-Value Worshipper?
por: Huak, Chan Yiong
Publicado: (2009)